Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BRAF RNA is prognostic and widely expressed in lung adenocarcinoma.
Dora D, Vörös I, Varga ZV, Takacs P, Teglasi V, Moldvay J, Lohinai Z. Dora D, et al. Among authors: teglasi v. Transl Lung Cancer Res. 2023 Jan 31;12(1):27-41. doi: 10.21037/tlcr-22-449. Epub 2023 Jan 13. Transl Lung Cancer Res. 2023. PMID: 36762067 Free PMC article.
Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma.
Reiniger L, Téglási V, Pipek O, Rojkó L, Glasz T, Vágvölgyi A, Kovalszky I, Gyulai M, Lohinai Z, Rásó E, Tímár J, Döme B, Szállási Z, Moldvay J. Reiniger L, et al. Among authors: teglasi v. Acta Oncol. 2019 Aug;58(8):1087-1094. doi: 10.1080/0284186X.2019.1598575. Epub 2019 Apr 19. Acta Oncol. 2019. PMID: 31002007
EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study.
Gieszer B, Megyesfalvi Z, Dulai V, Papay J, Kovalszky I, Timar J, Fillinger J, Harko T, Pipek O, Teglasi V, Regos E, Papp G, Szallasi Z, Laszlo V, Renyi-Vamos F, Galffy G, Bodor C, Dome B, Moldvay J. Gieszer B, et al. Among authors: teglasi v. Transl Lung Cancer Res. 2021 Feb;10(2):662-674. doi: 10.21037/tlcr-20-814. Transl Lung Cancer Res. 2021. PMID: 33718012 Free PMC article.
Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients.
Rojkó L, Reiniger L, Téglási V, Fábián K, Pipek O, Vágvölgyi A, Agócs L, Fillinger J, Kajdácsi Z, Tímár J, Döme B, Szállási Z, Moldvay J. Rojkó L, et al. Among authors: teglasi v. J Cancer Res Clin Oncol. 2018 Jul;144(7):1219-1226. doi: 10.1007/s00432-018-2642-4. Epub 2018 Apr 19. J Cancer Res Clin Oncol. 2018. PMID: 29675791
Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.
Téglási V, Reiniger L, Fábián K, Pipek O, Csala I, Bagó AG, Várallyai P, Vízkeleti L, Rojkó L, Tímár J, Döme B, Szállási Z, Swanton C, Moldvay J. Téglási V, et al. Neuro Oncol. 2017 Aug 1;19(8):1058-1067. doi: 10.1093/neuonc/now309. Neuro Oncol. 2017. PMID: 28201746 Free PMC article.
Prostate-specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain.
Tanjore Ramanathan J, Lehtipuro S, Sihto H, Tóvári J, Reiniger L, Téglási V, Moldvay J, Nykter M, Haapasalo H, Le Joncour V, Laakkonen P. Tanjore Ramanathan J, et al. Among authors: teglasi v. J Cell Mol Med. 2020 Jun;24(12):6916-6927. doi: 10.1111/jcmm.15350. Epub 2020 May 11. J Cell Mol Med. 2020. PMID: 32390293 Free PMC article.
Altered microRNA expression in folliculotropic and transformed mycosis fungoides.
Marosvári D, Téglási V, Csala I, Marschalkó M, Bödör C, Timár B, Csomor J, Hársing J, Reiniger L. Marosvári D, et al. Among authors: teglasi v. Pathol Oncol Res. 2015 Jul;21(3):821-5. doi: 10.1007/s12253-015-9897-8. Epub 2015 Feb 20. Pathol Oncol Res. 2015. PMID: 25698383 Free article.
11 results